Related Experiment Video

Updated: Aug 17, 2026

Intravascular Perfusion of Carbon Black Ink Allows Reliable Visualization of Cerebral Vessels
13:16

Intravascular Perfusion of Carbon Black Ink Allows Reliable Visualization of Cerebral Vessels

Published on: January 4, 2013

[The effect of pyritinol on the human cerebrovascular circulation (author's transl)]

H Herrschaft

    MMW, Munchener Medizinische Wochenschrift
    |September 29, 1978
    PubMed

    More Related Videos

    Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry07:12

    Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry

    Published on: January 19, 2020

    Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo06:24

    Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo

    Published on: July 8, 2025

    Related Concept Videos

    Pyruvate Oxidation01:15

    Pyruvate Oxidation

    After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
    First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
    The Blood-brain Barrier00:49

    The Blood-brain Barrier

    Overview
    Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

    Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

    Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
    TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...